1 |
Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetes in the Framingham population. Sixteenyear follow-up study. Diabetes 23: 105-111, 1974
DOI
|
2 |
Hsich E, Segal BH, Pagano PJ, Rey FE, Paigen B, Deleonardis J, Hoyt RF, Holland SM, Finkel T. Vascular effects following homozygous disruption of p47(phox): an essential component of NADPH oxidase. Circulation 101: 1234-1236, 2000
DOI
ScienceOn
|
3 |
Kannel WB, Catelli WP, Gordon T, Macnamara PM. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. Ann Intern Med 74: 1-12, 1971
DOI
ScienceOn
|
4 |
Karasu C Ozansoy G, Bozkurt O, Erdogan D, Omeroglu S. Antioxidant and triglyceride-lowering effects of vitamin E associated with the prevention of abnormalities in the reactivity and morphology of aorta from streptozotocin-diabetic rats. Antioxidants in Diabetes-Induced Complications (ADIC) Study Group. Metabolism 46: 872-879, 1997
DOI
ScienceOn
|
5 |
Karin E, Bornfeldt. Intracellular signaling in arterial smooth muscle migration versus proliferation. Trends Cardiovasc Med 6: 143-151, 1996
DOI
ScienceOn
|
6 |
Kawano M, Koshikawa T, Kanzaki T, Morisaki N, Saito Y, Yoshida S. Diabetes mellitus induces accelerated growth of aortic smooth muscle cells: association with overexpression of PDGF betareceptors. Eur J Clin Invest 23: 84-90, 1993
DOI
ScienceOn
|
7 |
Kojda G, Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res 43: 562-571, 1999
DOI
ScienceOn
|
8 |
Larson DM, Haudenschild CC. Activation of smooth muscle cell outgrowth from BB/Wor rat aortas. Diabetes 37: 1380-1385, 1988
DOI
ScienceOn
|
9 |
Lee JS, Kypreos KE, Sonenshein GE. Synchronization of cultured vascular smooth muscle cells following reversal of quiescence induced by treatment with the antioxidant N-acetylcysteine. Exp Cell Res 2: 447-453, 1998
|
10 |
Majander A, Finel M, Wikstrom M. Diphenyleneiodonium inhibits reduction of iron-sulfur clusters in the mitochondrial NADHubiquinone oxidoreductase (Complex I). J Biol Chem 269: 21037 -21042, 1994
|
11 |
Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 75: 487-517, 1995
PUBMED
|
12 |
Ushio-Fukai M, Zafari M, Fukui T, Ishizaka N, Griendling KK. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 271: 23317-23321, 1996
DOI
ScienceOn
|
13 |
Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK, Lambeth JD. Cell transformation by the superoxide-generating oxidase Mox1. Nature 100: 1494-1498, 1999
|
14 |
Mohazzab KM, Kaminski PM, Wolin MS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol 266: H2568-H2572, 1994
|
15 |
Kannel WB, McGree DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 241: 2035-2038, 1979
DOI
|
16 |
Kim YK, Lee MS, Son SM, Kim IJ, Lee WS, Rhim BY, Hong KW, Kim CD. Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes. Diabetes 51: 522-527, 2002
DOI
ScienceOn
|
17 |
Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315-1321, 1988
DOI
ScienceOn
|
18 |
Inoguchi T, Li P, Umeda F, Yu HK, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49: 1939-1945, 2000
DOI
ScienceOn
|
19 |
Cahilly C, Ballantyne CM, Lim DS, Gotto A, Marian AJ. A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. Circ Res 86: 391-395, 2000
DOI
ScienceOn
|
20 |
Karasu C. Time course of changes in endothelium-dependent and-independent relaxation of chronically diabetic aorta: role of reactive oxygen species. Eur J Pharmacol 392: 163-173, 2000
DOI
ScienceOn
|
21 |
White CR, Darley-Usmar V, Berrington WR, McAdams M, Gore JZ, Thompson JA, Parks DA, Tarpey MM, Freeman BA. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc Natl Acad Sci USA 93: 8745 -8749, 1996
DOI
ScienceOn
|
22 |
Bayraktutan U, Draper N, Lang D, Shah AM. Expression of functional neutrophil-type NADPH oxidase in cultured rat coronary microvascular endothelial cells. Cardiovasc Res 38: 256 -262, 1998
DOI
ScienceOn
|
23 |
Giugliano D, Periello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 19: 257-267, 1996
DOI
ScienceOn
|
24 |
Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BS, Karoui H, Tordo P, Pritchard KA Jr. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA 95: 9220-9225, 1998
DOI
ScienceOn
|
25 |
Stout RW. Insulin-stimulated lipogenesis in arterial tissue in relation to diabetes and atheroma. Lancet 2: 702-703, 1968
|
26 |
Griendling KK, Alexander RW. Oxidative stress and cardiovascular disease. Circulation 96: 3264-3265, 1997
|
27 |
Absher P, Schneider D, Baldor L, Russell J, Sobel B. The retardation of vasculopathy induced by attenuation of insulin resistance in the corpulent JCR:LA-cp rat is reflected by decreased vascular smooth muscle cell proliferation in vivo. Atherosclerosis 143: 245-251, 1999
DOI
ScienceOn
|
28 |
Bern MM. Platelet functions in diabetes mellitus. Diabetes 27: 42- 50, 1978
DOI
ScienceOn
|
29 |
Melton LJ 3rd, Macken KM, Palumbo PJ, Elveback LR. Incidence and prevalence of clinical peripheral vascular disease in a population-based cohort of diabetic patients. Diabetes Care 3: 650-654, 1980
DOI
ScienceOn
|
30 |
Warnholtz A, Nickenig G, Schulz E, Macharzina R, Brasen JH, Skatchov M, Heitzer T, Stasch JP, Griendling KK, Harrison DG, Bohm M, Meinnertz T, Munzel T. Increased NADH-oxidasemediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation 99: 2027-2033, 1999
DOI
ScienceOn
|
31 |
Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74: 1141- 1148, 1994
DOI
ScienceOn
|
32 |
Ross R. Cell biology of atherosclerosis. Annu Rev Physiol 57: 791- 804, 1995
DOI
ScienceOn
|
33 |
Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, Yokoyama M. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 97: 135-137, 1998
DOI
ScienceOn
|
34 |
Kimura I, Nagamori A, Honda R, Kobayashi S. Glycated serum stimulation of macrophages in GK- and streptozotocin-rats for the proliferation of primary cultured smooth muscle cells of the aorta. Immunopharmacology 40: 105-118, 1998
DOI
ScienceOn
|